Can Prostate Cancer Really Respond to Immunotherapy?

被引：3
|
作者：
Kim, Won [1 ]
Fong, Lawrence [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 01期
关键词：
CELL LUNG-CANCER; ELM-PC; 5; UNTREATED MELANOMA; DOUBLE-BLIND; NIVOLUMAB; DOCETAXEL; IPILIMUMAB; TRIAL; CHEMOTHERAPY; MULTICENTER;
D O I：
10.1200/JCO.2016.70.4791
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / +
页数：3
相关论文
共 50 条
  • [1] Immunotherapy for metastatic prostate cancer: do we really need this?
    Heidenreich, A.
    UROLOGE, 2012, 51 (01): : 32 - 38
  • [2] Can we really reduce the risk for prostate cancer?
    Steiner, MS
    WORLD JOURNAL OF UROLOGY, 2003, 21 (01) : 1 - 2
  • [3] Can we really reduce the risk for prostate cancer?
    Mitchell S. Steiner
    World Journal of Urology, 2003, 21 : 1 - 2
  • [4] Electronic nose can sniff out which patients with lung cancer will respond to immunotherapy
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (10) : 564 - 564
  • [5] Immunotherapy of prostate cancer
    Doehn, Christian
    EUROPEAN UROLOGY, 2008, 53 (04) : 681 - 683
  • [6] Immunotherapy for prostate cancer
    Karnes, RJ
    Whelan, CM
    Kwon, ED
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (07) : 807 - 817
  • [7] The immunotherapy of prostate cancer
    Dalgleish, AG
    Perry, MJA
    Eaton, JD
    Hrouda, D
    Todryk, SM
    Kirby, RS
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 303 - 307
  • [8] Immunotherapy in Prostate Cancer
    Bolat, Deniz
    Haydaroyu, Ayfer
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2019, 18 (02): : 67 - 72
  • [9] Immunotherapy for prostate cancer
    Fong, L
    Small, EJ
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 649 - 658
  • [10] Prostate Cancer Immunotherapy
    Karan, Dev
    Van Veldhuizen, Peter
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (04) : 237 - 237
12345